Synthesis of enantiomerically pure inherently chiral calix[4]arenes using the meta-substitution strategy
[Display omitted] •meta-Substituted aminocalix[4]arene was acylated by amino acids derivatives (Phe, Ala).•The combination of inherent chirality with chiral AAs led to diastereomers separable by preparative TLC.•Cyclization with Tf2O/2-ClPyr yielded the corresponding enantiomerically pure oxazoles.•...
Saved in:
Published in: | Tetrahedron letters Vol. 60; no. 3; pp. 260 - 263 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Ltd
17-01-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•meta-Substituted aminocalix[4]arene was acylated by amino acids derivatives (Phe, Ala).•The combination of inherent chirality with chiral AAs led to diastereomers separable by preparative TLC.•Cyclization with Tf2O/2-ClPyr yielded the corresponding enantiomerically pure oxazoles.•Straightforward and scalable approach towards enantiomerically pure inherently chiral calix[4]arenes.
A meta-substituted aminocalix[4]arene 4 immobilized in the cone conformation was prepared via mercuration of the starting tetra-propoxy derivative, followed by nitrosation and reduction reactions. Acylation of the amino group by chiral amino acid residues ((S)-N-trifluoroacetyl-Ala or (S)-N-trifluoroacetyl-Phe) allowed for the preparation of diastereomeric amides that were separated by preparative TLC on silica gel. Subsequent cyclization under Bischler-Napieralski reaction conditions yielded calixarenes 7b and 7c bearing an oxazole moiety in the meta position instead of the expected upper rim-bridged compounds. The reaction sequence represents a straightforward approach towards enantiomerically pure inherently chiral calix[4]arene derivatives (without HPLC separation steps). The absolute configuration of the enantiomers were confirmed by single crystal structure determination (X-ray). |
---|---|
ISSN: | 0040-4039 1873-3581 |
DOI: | 10.1016/j.tetlet.2018.12.026 |